Avenacy
Avenacy is a startup headquartered in Schaumburg, United States, founded in 2023. It has raised at least $26.0m in outside funding, according to its filings with the US Securities and Exchange Commission (Form D), which puts it at the early stage.
Part of the 311 Institute Global Startups Directory (311institute.com). Last updated .
Funding
Avenacy has raised at least $26.0m in outside funding, according to its Form D filings with the US Securities and Exchange Commission. Form D figures are a minimum: not every round is filed.
R&D ecosystem
Avenacy sits inside the Chicago R&D ecosystem in the Global R&D Labs Directory.
Related
- Innovation profile of Schaumburg
- United States: economy and key statistics
- Global Investors Directory
- All 311 Indexes
Questions and answers
What does Avenacy do?
Avenacy is classed in pharmaceuticals in its filings with the US Securities and Exchange Commission.
How much has Avenacy raised?
At least $26.0m, according to its Form D filings with the US Securities and Exchange Commission.
Where is Avenacy based?
Avenacy is headquartered in Schaumburg, United States.
When was Avenacy founded?
Avenacy was founded in 2023.
Source record: SEC EDGAR (Form D filings).
© 311 Institute 2026. Facts from the official sources linked on this page. The selection, classification and links are the proprietary work of the 311 Institute, protected by copyright and database rights.